MTOR and endometrial cancer: Consistent with our findings of KIF1B's inflammatory regulatory role, a previous study demonstrated that KIF5B, a kinesin family member closely related to KIF1B, regulates epithelial–mesenchymal transition through the PI3K/AKT/mTOR inflammatory pathway in endometrial cancer [29].